PATENT CLAIM ANALYSIS

Application Number: 15772587
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-03
Patent Classification: ["544", "262000"]

Abstract:
Compounds of the formula I in which Z, W, Q, R and Y have the meanings indicated in claim  1 , are inhibitors of Tankyrase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.

Claim (Index 6):
A method for the treatment and/or prevention of diseases selected from the group cancer of head, neck, eye, mouth, throat, esophagus, bronchus, larynx, pharynx, chest, bone, lung, colon, rectum, stomach, prostate, urinary bladder, uterine, cervix, breast, ovaries, testicles or other reproductive organs, skin, thyroid, blood, lymph nodes, kidney, liver, pancreas, brain, central nervous system, solid tumors and blood-borne tumors, comprising administering a compound of  claim 1  or a pharmaceutically acceptable salt, solvate or tautomer thereof, including mixtures thereof in any ratio.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 93.0
- Lexical Diversity: 1.40476
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14909365', '15308974', '13383605', '16069326', '14378009']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7721973096558279
- 35 USC 102 Novelty (BERT): 0.5523232258417791
- Combined Prediction Score: 0.750209901274423
- Mean Citation Score: 375.466308
- Max Citation Score: 428.29956
- Similarity Product: 311.0352184378767

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test